Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients.
González-Salvatierra S, García-Fontana C, Andújar-Vera F, Grau-Perales AB, Martínez-Heredia L, Avilés-Pérez MD, Hayón-Ponce M, Iglesias-Baena I, Riquelme-Gallego B, Muñoz-Torres M, García-Fontana B.
González-Salvatierra S, et al.
J Clin Med. 2021 May 20;10(10):2209. doi: 10.3390/jcm10102209.
J Clin Med. 2021.
PMID: 34065223
Free PMC article.